Wistar Morris

The Wistar Institute is a world-renowned, independent, nonprofit biomedical research organization located in Philadelphia, Pennsylvania. Founded in 1892 as the first independent research facility in the United States, it is a National Cancer Institute (NCI)-designated Cancer Center specializing in oncology, immunology, and infectious diseases. Wistar is historically significant for developing major vaccines for rubella, rabies, and rotavirus, and it continues to drive innovation through a robust technology transfer program that licenses discoveries to global pharmaceutical and biotech partners. The institute maintains a diverse pipeline of therapeutic candidates, including synthetic DNA vaccines and novel small molecule inhibitors, often developed in collaboration with industry leaders like Inovio Pharmaceuticals.